Docket Room
HB 1231·LA·house

MEDICAID MANAGED CARE: Provides relative to Medicaid coverage for continuous glucose monitoring devices for individuals with certain conditions (EN NO IMPACT See Note)

Signed into LawFiled Mar 31, 2026
Sponsor: Stephanie Berault (R)
Latest Action

Signed by the Governor. Becomes Act No. 889.

Jun 9, 2026

Summary

The bill amends Louisiana law to require the Medicaid program to pay for continuous glucose monitoring devices for enrollees who have any type of diabetes, including gestational diabetes during pregnancy. Coverage applies to patients who need insulin more than twice daily or who have level 2 or level 3 hypoglycemia. The change is intended to improve diabetes management and health outcomes for mothers and their babies.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 1231 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice